ABSTRACT
Background
In
recent
years,
the
utilization
of
stem
cell
therapy
and
sheet
technology
has
emerged
as
a
promising
approach
for
addressing
spinal
cord
injury
(SCI).
However,
most
appropriate
type
mechanism
action
remain
unclear
at
this
time.
This
study
sought
to
develop
an
SCI
rat
model
evaluate
therapeutic
effects
human
umbilical
mesenchymal
(hUC‐MSC)
sheets
in
model.
Furthermore,
mechanisms
underlying
vascular
repair
effect
hUC‐MSC
following
were
investigated.
Methods
A
temperature‐responsive
culture
method
was
employed
preparation
sheets.
The
extracellular
matrix
(ECM)
produced
by
hUC‐MSCs
serves
two
distinct
yet
interrelated
purposes.
Firstly,
it
acts
biologically
active
scaffold
transplanted
cells,
facilitating
their
attachment
proliferation.
Secondly,
provides
mechanical
support
bridges
stumps,
thereby
restoration
function.
formation
cavity
within
evaluated
using
Hematoxylin
Eosin
(H&E)
staining
method.
Subsequently,
endothelial
cells
cultivated
with
conditioned
medium
(CM)
obtained
from
or
pro‐angiogenic
impact
(MSC‐CM)
(CS‐CM)
through
CCK‐8
assay,
wound
healing
tube
assay
vitro
context.
development
glial
scars,
blood
vessels,
neurons,
axons
assessed
immunofluorescence
staining.
Results
comparison
hUC‐MSCs,
demonstrated
more
pronounced
capacity
facilitate
induce
regeneration
newborn
neurons
site,
while
also
reducing
scar
significantly
enhancing
motor
function
rats.
Notably,
under
identical
conditions,
been
associated
paracrine
increase
ability
themselves
secrete
growth
factors.
During
course
experiment,
observed
that
secretion
uPAR
among
factors
present
MSC‐CM
CS‐CM.
finding
subsequently
corroborated
subsequent
experiments,
wherein
promote
angiogenesis
via
PI3K/Akt
signaling
pathway.
Conclusion
creation
not
only
enhances
biological
but
effectively
retains
locally
injury.
Therefore,
transplantation
can
maximize
greatly
formation,
promoting
axons.
Additionally,
research
findings
prove
activate
pathway
enhance
angiogenesis.
transfer
entire
sheets,
absence
introduction
additional
exogenous
synthetic
biomaterials,
further
augment
potential
clinical
application.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(23)
Published: Feb. 14, 2024
Abstract
Cell
therapy
is
a
promising
approach
for
myocardial
infarction
(MI)
treatment.
However,
this
strategy
often
restricted
by
the
harsh
microenvironment
of
MI,
such
as
excess
ROS,
high
oxidative
stress,
inflammation,
etc.,
and
thus
decreases
curative
effect.
Additionally,
distribution,
migration,
homing
transplanted
stem
cells
ambiguous,
which
also
becomes
bottleneck
clinical
translation.
To
address
these
challenges,
herein,
versatile
antioxidant
nanozyme
designed
polymerically
modifying
dopamine
(PDA)
onto
surface
Mn
3
O
4
.
The
obtained
acts
an
efficient
SOD
mimic,
eliminating
relieving
reducing
inflammation
to
improve
MI
microenvironment.
Simultaneously,
@PDA
serves
excellent
MRI
contrast
agent
tracking
MSCs.
Then,
MSCs
are
engineered
with
via
endocytosis
form
@PDA‐MSCs
(Abbr.
E‐MSCs),
possess
superior
viability,
migration
ability
compared
normal
Furthermore,
E‐MSCs
exhibit
anti‐oxidant
anti‐inflammatory
activity,
thereby
enhancing
therapeutic
efficacy
Finally,
in
vivo
synergistic
potential
explored
model
mice.
Overall,
work
provides
combine
activity
imaging
properties
nanozymes
simultaneously
facilitate
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(26), P. 16450 - 16467
Published: June 19, 2024
Nanozymes,
which
can
selectively
scavenge
reactive
oxygen
species
(ROS),
have
recently
emerged
as
promising
candidates
for
treating
ischemic
stroke
and
traumatic
brain
injury
(TBI)
in
preclinical
models.
ROS
overproduction
during
the
early
phase
of
these
diseases
leads
to
oxidative
damage,
has
been
a
major
cause
mortality
worldwide.
However,
clinical
application
ROS-scavenging
enzymes
is
limited
by
their
short
vivo
half-life
inability
cross
blood-brain
barrier.
mimic
catalytic
function
natural
enzymes,
several
advantages,
including
cost-effectiveness,
high
stability,
easy
storage.
These
advantages
render
them
superior
disease
diagnosis
therapeutic
interventions.
This
review
highlights
recent
advancements
nanozyme
applications
TBI,
emphasizing
potential
mitigate
detrimental
effect
overproduction,
inflammation,
barrier
compromise.
Therefore,
nanozymes
represent
treatment
modality
conditions
future
medical
practices.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(4), P. 4375 - 4394
Published: Jan. 8, 2024
RNA
interference-based
gene
therapy
has
led
to
a
strategy
for
spinal
cord
injury
(SCI)
therapy.
However,
there
have
been
high
requirements
regarding
the
optimal
delivery
vector
siRNA-based
SCI
Here,
we
developed
an
injectable
and
photocurable
lipid
nanoparticle
GelMA
(PLNG)
hydrogel
scaffold
controlled
dual
siRNA
at
wound
site.
The
prepared
PLNG
could
efficiently
protect
retain
bioactivity
of
nanocomplex.
It
facilitated
sustainable
release
along
with
degradation
in
7
days.
After
loading
targeting
phosphatase
tensin
homologue
(PTEN)
macrophage
migration
inhibitory
factor
(MIF)
simultaneously,
locally
administered
siRNAs/PLNG
improved
Basso
mouse
scale
(BMS)
score
recovered
ankle
joint
movement
plantar
stepping
after
treatment
only
three
doses.
We
further
proved
that
successfully
regulated
activities
neurons,
microglia,
macrophages,
thus
promoting
neuron
axon
regeneration
remyelination.
protein
array
results
suggested
increase
expression
growth
factors
decrease
inflammatory
regulate
neuroinflammation
create
neural
repair
environment.
Our
system
is
potential
candidate
Bioactive Materials,
Journal Year:
2024,
Volume and Issue:
39, P. 521 - 543
Published: May 30, 2024
Spinal
cord
injury
(SCI)
often
results
in
irreversible
loss
of
sensory
and
motor
functions,
most
SCIs
are
incurable
with
current
medical
practice.
One
the
hardest
challenges
treating
SCI
is
development
a
dysfunctional
pathological
microenvironment,
which
mainly
comprises
excessive
inflammation,
deposition
inhibitory
molecules,
neurotrophic
factor
deprivation,
glial
scar
formation,
imbalance
vascular
function.
To
overcome
this
challenge,
implantation
functional
biomaterials
at
site
has
been
regarded
as
potential
treatment
for
modulating
microenvironment
to
support
axon
regeneration,
remyelination
site,
recovery
after
SCI.
This
review
summarizes
characteristics
recent
advances
well
technologies
used
modulate
inflammatory
regulate
reshape
revascularization
microenvironment.
Moreover,
technological
limitations,
challenges,
future
prospects
promote
efficient
repair
also
discussed.
will
aid
further
understanding
Advanced Functional Materials,
Journal Year:
2023,
Volume and Issue:
34(3)
Published: Oct. 15, 2023
Abstract
Recently,
neurological
disorders
have
led
to
a
growing
global
burden
of
fatalities
and
disabilities.
The
limited
capacity
for
natural
self‐regeneration
poses
significant
challenge
in
repairing
nervous
system
injuries,
which
is
closely
related
the
complex
microenvironment
nonregenerative
nature
neurons.
Metal–organic
frameworks
(MOFs),
with
their
distinctive
structure
properties
including
high
surface
area,
porosity,
tunability,
stimuli‐responsive
behavior,
biocompatibility,
biodegradability,
stand
as
an
auspicious
platform
devising
therapeutic
strategies
aiming
at
nerve
regeneration
repair.
By
taking
advantage
these
characteristics,
researchers
opportunity
explore
innovative
methods
endogenous
stimulation,
magnetic
response
therapy,
phototherapy,
ultrasound
drug
delivery
systems
treatment
diseases.
Moreover,
MOFs‐based
stem
cell
therapy
also
developed
inhibit
neuroinflammation
oxidative
stress,
promote
axon
growth,
regulate
differentiation,
regeneration,
finally
restore
function
injured
nerves.
In
this
paper,
preparation
strategy
biological
characteristics
MOFs,
highlighting
applications
injuries
treating
neural
cells
presented.
Finally,
outlook
on
future
development
challenges
field
neuroscience
concerning
MOFs
provided.
Drug Delivery,
Journal Year:
2024,
Volume and Issue:
31(1)
Published: Oct. 25, 2024
Hydrogels,
comprising
3D
hydrophilic
polymer
networks,
have
emerged
as
promising
biomaterial
candidates
for
emulating
the
structure
of
biological
tissues
and
delivering
drugs
through
topical
administration
with
good
biocompatibility.
Nanozymes
can
catalyze
endogenous
biomolecules,
thereby
initiating
or
inhibiting
in
vivo
processes.
A
nanozyme-hydrogel
composite
inherits
functions
hydrogels
nanozymes,
where
nanozyme
serves
catalytic
core
hydrogel
forms
structural
scaffold.
Moreover,
concentrate
nanozymes
targeted
lesions
binding
a
specific
group
substrates,
resulting
pathological
microenvironment
remodeling
drug-penetrating
barrier
impairment.
The
also
shields
to
prevent
burst
release
during
production
reduce
related
toxicity.
Currently,
application
these
composites
has
been
extended
antibacterial,
anti-inflammatory,
anticancer,
tissue
repair
applications.
In
this
review,
we
elucidate
preparation
methods
composites,
provide
compelling
evidence
their
advantages
drug
delivery
comprehensive
overview
application.